Differential osteopontin expression in lung cancer (Q40784031)

23 September 2017

Differential osteopontin expression in lung cancer (English)

1 reference

23 September 2017

Zhang J

1

1 reference

23 September 2017

Takahashi K

2

1 reference

23 September 2017

Takahashi F

3

1 reference

23 September 2017

Shimizu K

4

1 reference

23 September 2017

Ohshita F

5

1 reference

23 September 2017

Kameda Y

6

1 reference

23 September 2017

Maeda K

7

1 reference

23 September 2017

Nishio K

8

1 reference

23 September 2017

Fukuchi Y

9

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

23 September 2017

1 reference

23 September 2017

171

1 reference

23 September 2017

2

1 reference

23 September 2017

215-222

1 reference

K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

7 January 2021

Osteopontin: a protein with diverse functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

1 reference

7 January 2021

A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

7 January 2021

Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

7 January 2021

Osteopontin expression in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

7 January 2021

Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

7 January 2021

Co-expression of osteopontin and CD44v9 in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

7 January 2021

Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

7 January 2021

Regulation and function of osteopontin in ras-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

7 January 2021

Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

7 January 2021

Osteopontin is required for full expression of the transformed phenotype by the ras oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

7 January 2021

ras mutation and expression of theras-regulated genes osteopontin and cathepsin L in human esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900607-3

7 January 2021

10.1016/S0304-3835(01)00607-3

Identifiers

DOI

1 reference

23 September 2017

1 reference